OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use</p>
Angelo Cagnacci, Anjeza Xholli, Martina Venier
Patient Preference and Adherence (2020) Vol. Volume 14, pp. 55-62
Open Access | Times Cited: 20

Showing 20 citing articles:

Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-dependent Breast Cancer

Obstetrics and Gynecology (2021) Vol. 138, Iss. 6, pp. 950-960
Closed Access | Times Cited: 31

Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis
James A. Simon, Alex Ferenczy, Denise Black, et al.
Menopause The Journal of The North American Menopause Society (2023) Vol. 30, Iss. 8, pp. 855-866
Open Access | Times Cited: 11

Polycarbophil vaginal moisturizing gel versus hyaluronic acid gel in women affected by vaginal dryness in late menopausal transition: A prospective randomized trial
Angelo Cagnacci, Dionisio Franco Barattini, Elena Casolati, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2022) Vol. 270, pp. 239-245
Open Access | Times Cited: 14

From diagnosis to survivorship addressing the sexuality of women during cancer
Rebekah Kaufman, Laila Agrawal, Eleonora Teplinsky, et al.
The Oncologist (2024) Vol. 29, Iss. 12, pp. 1014-1023
Open Access | Times Cited: 2

Impact of vulvovaginal atrophy therapies on postmenopausal women's quality of life in the CRETA study measured by the Cervantes scale
Santiago Palacios, Rafael Sánchez-Borrego, Beatriz Suárez Álvarez, et al.
Maturitas (2023) Vol. 172, pp. 46-51
Open Access | Times Cited: 6

Management of Hypertension with Female Sexual Dysfunction
Qing Peter Wild Zhong, Yuri Kamihagi Anderson
Medicina (2022) Vol. 58, Iss. 5, pp. 637-637
Open Access | Times Cited: 9

Posttreatment with Ospemifene Attenuates Hypoxia- and Ischemia-Induced Apoptosis in Primary Neuronal Cells via Selective Modulation of Estrogen Receptors
Bernadeta Angelika Pietrzak, Agnieszka Wnuk, Karolina Przepiórska, et al.
Neurotoxicity Research (2023) Vol. 41, Iss. 4, pp. 362-379
Open Access | Times Cited: 5

A review of the psychosocial factors that contribute to sexuality, female sexual dysfunction, and sexual pain among Muslim women
Arleen Lamba, Nadiah Mohajir, Sameena Rahman
Sexual Medicine Reviews (2023) Vol. 11, Iss. 3, pp. 156-173
Closed Access | Times Cited: 5

Ospemifene versus local estrogen: adherence and costs in postmenopausal dyspareunia
Brooke Faught, Graziella Soulban, Jason Yeaw, et al.
Journal of Comparative Effectiveness Research (2019) Vol. 8, Iss. 13, pp. 1111-1123
Closed Access | Times Cited: 13

A real-world disproportionality analysis of ospemifene: data mining of the public version of FDA adverse event reporting system
Haixiao Wen, Chong Lu, Meng Zhang, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 11, pp. 1133-1142
Closed Access | Times Cited: 4

Clinical guidelines for managing menopausal symptoms in women with (a history of) breast cancer
Jonathan Servayge, Ashley Verduyn, Anne Page, et al.
Facts Views and Vision in ObGyn (2023) Vol. 15, Iss. 4, pp. 297-308
Open Access | Times Cited: 4

Ospemifene and vulvovaginal atrophy: an update of the clinical profile for post-menopausal women
Costantino Di Carlo, Angelo Cagnacci, Filippo Murina, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 11, pp. 1541-1554
Open Access | Times Cited: 1

Efficacy of intradermal hyaluronic acid plus polynucleotides in vulvovaginal atrophy: a pilot study
Margherita Angelucci, F. Frascani, A. Franceschelli, et al.
Climacteric (2022) Vol. 25, Iss. 5, pp. 490-496
Closed Access | Times Cited: 4

Menopoz ve cinsel yaşam: Sistematik derleme
Fatma Aslan Demirtaş, Burcu Fırat, Nevin Hotun Şahin
Androloji Bülteni (2022)
Open Access | Times Cited: 3

Short and long-term effect of polycarbophil vaginal gel on vaginal atrophy of peri- and post-menopausal women. The TRIPLE study
Angelo Cagnacci, Dionisio Franco Barattini, Elena Casolati, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2024) Vol. 299, pp. 303-308
Open Access

Menopozun Cinsel İşlev Bozukluğuna ve Depresyona Etkisi: Vaka-Kontrol Çalışması
Fatma Yıldırım, Nuriye Büyükkayacı Duman, Gülşen Vural
STED / Sürekli Tıp Eğitimi Dergisi (2024)
Closed Access

Vulvovaginal atrophy in the CRETA study: the healthcare professionals’ perception
María Jesús Cancelo Hidalgo, Rafael Sánchez-Borrego, Santiago Palacios, et al.
Gynecological Endocrinology (2023) Vol. 39, Iss. 1
Open Access

Menopause and genitourinary health: optimal support and correction of disorders
O. V. Yakushevskaya
Meditsinskiy sovet = Medical Council (2022), Iss. 16, pp. 136-141
Open Access

Menopoz Semptomlarına Özgü Güncel Kanıt Temelli Uygulamalar
Burcu Öskan Fırat, Ergül Aslan
Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi (2022) Vol. 11, Iss. 4, pp. 1609-1618
Open Access

Page 1

Scroll to top